T. Reiman et al., Persistent preswitch clonotypic myeloma cells correlate with decreased survival: evidence for isotype switching within the myeloma clone, BLOOD, 98(9), 2001, pp. 2791-2799
Multiple myeloma (MM) is identified by unique immunoglobulin heavy chain (I
gH) variable diversity joining region gene rearrangements, termed clonotypi
c, and an M protein termed the "clinical" isotype. Transcripts encoding clo
notypic pre and postswitch IgH isotypes were identified in MM peripheral bl
ood mononuclear cells (PBMCs), bone marrow (BM), and mobilized blood. For 2
9 patients, 38 BM, 17 mobilized blood, and 334 sequential PBMC samples were
analyzed at diagnosis, before and after transplantation for 2 to 107 month
s. The clinical clonotypic isotype was readily detectable and persisted thr
oughout treatment. Eighty-two percent of BM and 38% of PBMC samples also ex
pressed nonclinical clonotypic isotypes. Clonotypic immunoglobulin M (IgM)
was detectable in 68% of BM and 25% of PBMC samples. Nonclinical clonotypic
isotypes were detected in 41% of mobilized blood samples, but clonotypic I
gM was detected in only 12%. Patients with persistent clonotypic IgM expres
sion had adverse prognostic features at diagnosis (lower hemoglobin, higher
beta (2)-microglobulin) and higher numbers of BM plasma cells compared wit
h patients with infrequent/absent clonotypic IgM. Patients with persistent
clonotypic IgM expression had significantly poorer survival than patients w
ith infrequent IgM expression (P < .0001). In a multivariate analysis, pers
istent clonotypic IgM expression in the blood correlated independently with
poor survival (P = .01). In nonobese diabetic severe combined immunodefici
ency mice, xenografted MM cells expressed clinical and nonclinical postswit
ch clonotypic isotypes. MM expressing clonotypic IgM engrafted both primary
and secondary mice, indicating their persistence within the murine BM. Thi
s study demonstrates that MM clonotypic cells expressing preswitch transcri
pts are tied to disease burden and outcomes. Because MM pathology involves
postswitch plasma cells, this raises the possibility that IgH isotype switc
hing in MM may accompany worsening disease. (C) 2001 by The American Societ
y of Hematology.